Xenon Pharmaceuticals Inc (XENE) NPV
1.28%- This stock can be held in a
Stocks and Shares ISASell:$34.63
Buy:$39.70
Change:
$0.33
(0.85%)
$0.33
(0.85%)Market closed | Prices delayed by at least 15 minutes
Sell:$34.63
Buy:$39.70
Change:$0.33
(0.85%)
$0.33
(0.85%)Market closed | Prices delayed by at least 15 minutes
Director deals
Listed below are trades carried out by directors and other individuals which are required to be notified to the market.
Recent deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 December 2024 | Sherry AulinCFO | Sell Option/Award related | 4,490 | $41.28 | $185,347.20 | 11,510 |
| 18 December 2024 | Sherry AulinCFO | Sell Option/Award related | 2,135 | $41.28 | $88,132.80 | 7,199 |
| 18 December 2024 | Sherry AulinCFO | Sell Option/Award related | 7,199 | $41.23 | $296,814.77 | 0 |
| 18 December 2024 | Sherry AulinCFO | Sell Option/Award related | 11,510 | $41.19 | $474,096.90 | 0 |
| 22 November 2024 | Gary PatouIndependent Director | Sell Tax related | 649 | $39.80 | $25,830.20 | 26,424 |
| 22 November 2024 | Gary PatouIndependent Director | Sell Tax related | 1,046 | $39.80 | $41,630.80 | 25,613 |
| 22 November 2024 | Gary PatouIndependent Director | Sell Option/Award related | 2,851 | $41.11 | $117,204.61 | 23,573 |
| 22 November 2024 | Gary PatouIndependent Director | Sell Option/Award related | 2,040 | $41.05 | $83,742.00 | 23,573 |
| 8 March 2024 | Elizabeth A (Betsy) GarofaloDirector | Sell Option/Award related | 1,408 | $46.16 | $64,993.28 | 2,092 |
| 8 March 2024 | Elizabeth A (Betsy) GarofaloDirector | Sell Option/Award related | 2,092 | $45.69 | $95,583.48 | 0 |
5 most significant deals
| Date | Name and position (if held) | Deal type | Number of shares dealt | Price per share | Value of trade | Shares remaining |
|---|---|---|---|---|---|---|
| 18 December 2024 | Sherry AulinCFO | Sell Option/Award related | 11,510 | $41.19 | $474,096.90 | 0 |
| 18 December 2024 | Sherry AulinCFO | Sell Option/Award related | 7,199 | $41.23 | $296,814.77 | 0 |
| 7 March 2024 | Robin Paul SherringtonExecutive Vice President | Sell Option/Award related | 6,118 | $46.30 | $283,263.40 | 8,398 |
| 7 March 2024 | Steven Richard GannonDirector | Sell Regular sell transaction (market) | 5,000 | $46.30 | $231,512.50 | 4,000 |
| 7 March 2024 | Steven Richard GannonDirector | Sell Regular sell transaction (market) | 5,000 | $46.25 | $231,250.00 | 9,000 |
Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Director deal information provided by Factset.